Approach to epilepsy POWER POINT---EDITED.ppt

download Approach to epilepsy POWER POINT---EDITED.ppt

of 41

Transcript of Approach to epilepsy POWER POINT---EDITED.ppt

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    1/41

    Approach to epilepsy

    evaluation and treatment of seizuresin ER

    history of epilepsy or first seizure e.g.

    poorly controlled epilepsy comesafter a seizure and has recovered to

    normal interictal stateAggressive lumbar punture repeatscans may not be necessary

    http://professionals.epilepsy.com/page/emergency_approach.htmlhttp://professionals.epilepsy.com/page/emergency_approach.html
  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    2/41

    .

    You cant attribute fever, focal

    weakness, or altered awareness to

    the post-ictal state

    may signal new or deteriorating

    disorders

    Individuals with epilepsy are still

    human and can any other disease

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    3/41

    .emergency EEG is useful in:-

    to distinguish successful resolution of

    convulsive status epilepticus from a

    conversion to subtle status epilepticus

    to rule out seizures as a cause of unusualbehavior or movements

    If muscle and movement artifacts present

    difficulty in interpreting these events, video-

    EEG can be extremely useful

    http://professionals.epilepsy.com/page/emergency_approach.htmlhttp://professionals.epilepsy.com/page/emergency_approach.html
  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    4/41

    Emergency neuroemaging CT or

    MRI

    Any change in the patients seizure

    pattern or type

    prolonged postictal confusion or

    worsening mental status. patients

    who have epilepsy with recurrent

    seizures whenever the physician

    suspects a serious structural lesion.

    http://professionals.epilepsy.com/page/emergency_approach.htmlhttp://professionals.epilepsy.com/page/emergency_approach.html
  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    5/41

    e.g

    new focal deficits

    persistent altered mental status (with or withoutintoxication with alcohol other substance)

    fever

    recent trauma

    persistent headache

    vomiting

    history of cancer

    history of anticoagulation

    suspicion of acquired immunodeficiency syndrome(AIDS)

    http://professionals.epilepsy.com/page/emergency_approach.htmlhttp://professionals.epilepsy.com/page/emergency_approach.htmlhttp://professionals.epilepsy.com/page/emergency_approach.htmlhttp://professionals.epilepsy.com/page/emergency_approach.html
  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    6/41

    .

    If an MRI scan --seizure protocol

    thin coronal cuts through the

    amygdala,

    hippocampus,

    mesial temporal regions,

    T1, T2, and FLAIR pulse sequences

    http://professionals.epilepsy.com/page/emergency_approach.htmlhttp://professionals.epilepsy.com/page/emergency_approach.html
  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    7/41

    Neck immobilization

    Spinal immobilization in individuals

    after seizures is rarely necessary. In

    one retrospective study, 1,656 cases

    over a 10-year period were reviewed,and no spinal injuries were found.[25]

    http://professionals.epilepsy.com/page/emergency_ref.htmlhttp://professionals.epilepsy.com/page/emergency_ref.html
  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    8/41

    Communication

    Contacting the patients treating

    physician is vital to good quality and

    continuity of care.

    In one study, AED therapy was

    altered by the ED in nearly 20% of

    epilepsy patients who were evaluated

    and discharged from an ED,

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    9/41

    Driving, swimming, cooking

    alone, working in risky areas

    e.g.moving machines, scaffoldReview issues of compliance with the

    patient, and inform him or her about

    the state laws that pertain to driving.

    Some countries by law you have to

    inform Department of Motor Vehicles

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    10/41

    , Figure: EEG demonstrating a single generalized

    polyspike-and-wave in second 2 and brief burst of

    generalized spike-and-waves in second 7

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    11/41

    What is strong of evindence of drug

    resistant epilepsy

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    12/41

    Status epilepticus is a neuologic

    .

    Status epilepticus is a neurologicemergency associated

    with high mortality and long-termdisability. Recent advances

    in our understanding of thepathophysiological

    mechanisms involved in the initiationand perpetuation of

    seizure activity have revealed thatstatus epilepticus is a

    dynamic and evolving process.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    13/41

    ,

    PATHOPHYSIOLOGY

    Status epilepticus represents a failure ofinherent cellular

    mechanisms to prevent sustained seizureactivity.22 These

    mechanisms are believed to fail secondaryto either persistent

    excitation of a cellular focus or ineffectiveinhibition of

    sustained seizure activity.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    14/41

    ,

    Results of experiments on brain slice

    preparations suggest that sustained seizureactivity

    requires the development of a reverberating circuit

    betweenentorhinal and hippocampal structures. #Thisappears

    to occur as an all-or-none phenomenon,# with

    seizuresbecoming self-sustaining after 15 to 30 minutes of

    stimulation.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    15/41

    ,

    These findings suggest that SE involves both anactivation

    and a maintenance phase.24 Activation may beinitiated

    by the presence of excessive excitatorystimulation. This

    concept was supported by the clinical observationof the

    development of SE in individuals after they

    inadvertentlyingested domoic acid, an analogue of anexcitatory amino

    acid.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    16/41

    ,

    Induced seizures may be sustained byfailure of -

    aminobutyric acid (GABA)-mediated

    suppression of anactivated focus. This resistance maydevelop through seizure-

    induced formation of varying isoforms of

    the GABAtype A (GABAA) receptor in thehippocampus.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    17/41

    ,

    Alternatively, SE may be perpetuatedby sustained Nmethyl-

    D-aspartate (NMDA)-mediated

    neuronal stimulation.27 In animal models, SE developed asensitivity toNMDA

    simultaneously with the developmentof progressive GABAAresistance.28,29

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    18/41

    ,

    It is believed that earlypharmacological administration

    of medication leads to termination of

    seizures withmuch smaller doses and withsubsequent less risk to the

    patient than would be required ifseizures were allowed to

    progress.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    19/41

    .

    important consideration in thetreatment of SE

    is the immediate need for EEG

    monitoring. Electrographicseizure activity has been reported tocontinue in up to 15%

    of patients whose overt clinicalseizures are pharmacologically

    controlled.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    20/41

    .

    out-of-hospital administration ofbenzodiazepines, a

    randomized double-blind trial comparingintravenous (IV)

    diazepam (5-10 mg) or lorazepam (2-4 mg)In many circumstances, IV access

    may be unavailable during emergencytransport; in

    these settings, rectal or intramuscularadministration of

    benzodiazepines may be effective.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    21/41

    ,

    Initial management of SE follows the principles of basic

    life support.2,8 The first priority is ensuring an adequate

    airway. Most patients with SE maintain adequate ventilation

    as long as an adequate airway is present.# Oral or

    nasopharyngeal devices supplemented with oxygen

    deliveredvia a nasal cannula or bag mask ventilation are usually

    adequate to maintain oxygenation and avoid hypoxemia;

    prolonged seizures, however, lead to loss of pharyngeal

    tone and increase the risk of aspiration. The timing of oral

    or nasal tracheal intubation is a clinical decision, but mostpatients who receive large doses of benzodiazepines or

    other sedative medications will require mechanicalventilatory support.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    22/41

    .

    Intubation can be problematic for patients with GCSE

    who may require neuromuscular blockade. If neuromuscular

    blockade is required, a short-acting nondepolarizing

    agent such as rocuronium bromide is preferred. If there is a

    possibility of rhabdomyolysis, succinylcholine chloride

    should be avoided because of potentialhyperkalemicinduced

    cardiac arrhythmias. Adequate peripheral IV access

    is needed to provide drugs and fluid resuscitation.

    Central access may be required if inotropes are needed for

    blood pressure support.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    23/41

    ,

    All patients should have continuous

    pulse oximetry and

    electrocardiographic monitoring. Of

    Cardiac arrhythmias

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    24/41

    .

    sudden death can occur in SE, presumably secondary to

    sympathetically mediated cardiac damage Hypoxemia is

    common and has many etiologies including apnea, airway

    obstruction, aspiration, and neurogenic pulmonary

    edema. Frequent monitoring of blood pressure and urinary

    output is crucial because hypotension is a commonadverse effect of several of the medications used to control

    seizures. More invasive monitoring may be required if the

    patient becomes hemodynamically unstable. Continuous

    EEG monitoring is required in all patients who receive

    long-term neuromuscular paralytic agents, have a prolongedpostictal period, are being treated for refractory SE

    (RSE), or have atypical features to their seizures suggestive

    of pseudoseizures.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    25/41

    ,

    Routine laboratory evaluation includes serum electrolytes,glucose, magnesium, calcium, liver function tests,

    complete blood cell count, creatine kinase, toxicology

    screen, and antiepileptic medication levels. Treatment

    should be based on the findings of this evaluation. A bedside

    glucose level should be attained as soon as possibleand 100 mg of thiamine and 50 mL of 50% glucoseadministered

    if hypoglycemia is present.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    26/41

    ,

    In GCSE, a metabolicacidosis inevitably is found and reflects sustained muscular

    activity. This acidosis is self-correcting once seizures are

    controlled and rarely requires treatment. Arterial blood gas

    testing may reveal hypoxia or a respiratory acidosis that

    requires ventilatory support.Hyperthermia augments

    neuronal damage due to sustained seizure activity and

    should be treated aggressively with active cooling

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    27/41

    .

    A full diagnostic evaluation should be initiated on thepatients arrival at the emergency department. Pertinent

    historical features include any recent change in medication,

    alcohol or drug use, previous epilepsy, or neurologic insult.

    If witnessed, a description of the onset and initial features

    of the seizure may be helpful. In the absence of a knownseizure disorder, computed tomography of the head should

    be performed once the patient is stabilized and seizures are

    controlled. The threshold for obtaining cerebrospinal fluid

    should be low.

    MPsUrine toxic screen

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    28/41

    ,

    Benzodiazepines.

    Benzodiazepines are an antiepilepticmedication used for the initial treatment of SE. They

    are a class of drugs that act at the GABAA receptor.Stimulation

    of this subunit leads to inhibition of neural transmission

    through hyperpolarization of the resting cell membrane.This is accomplished through the GABA-induced

    opening of chloride channels, which allows for intracellular

    chloride influx.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    29/41

    .

    At higher concentrations, benzodiazepines reduce repetitiveneuronal firing by a mechanism

    similar to that of phenytoin and carbamazepine.

    Diazepam achieves higher brain concentrations and has a

    slightly faster onset of action,

    although , Because of high lipidsolubility, diazepam is redistributed rapidly to peripheral

    fat stores. This property limits its clinical effectiveness to

    only 20 to 30 minutes and accounts for its large relapse

    rate

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    30/41

    .

    Phenytoin and Fosphenytoin.

    Phenytoin (5,5-diphenyl-2,4-imidazolidinedione) is a barbiturate-like drug that

    is effective in controlling seizure activity. It limits the

    repetitive firing of action potentials through the slowing of

    the rate of recovery of voltage-activated sodium channels.

    Phenytoin is formulated with propylene glycol and ethanoland is adjusted to pH 12 with sodium hydroxide. It is highly

    protein-bound with only the free portion being metabolically

    active. Maintaining appropriate drug levels can be

    problematic because of multiple drug interactions and the

    saturable pharmacokinetics of hepatic metabolism andprotein binding.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    31/41

    .

    The loading dose of phenytoin for SE is 20 mg/kg innonglucose-containing solutions administered at a maximal

    rate of 50 mg/min

    A gram of phenytoin is commonly

    given, but this is an insufficient loading dose for

    most adult patients.In the absence of clinical effect, an

    additional 10 mg/kg is given because many patients may

    require serum levels of approximately 25 to 30 gm/mL to

    achieve seizure control.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    32/41

    . phenytoin

    adverse effects SE are cardiovascular, includinghypotension, QT prolongation,

    cardiac dysrhythmias. Most can be attenuated

    by reducing the infusion rate. The effects are attributable to

    a direct effect of both the medication and the propylene

    glycol used as a diluent.14The most problematic adverse effect is severe tissue

    reaction that can occur with extravasation of phenytoin into

    adjacent tissue. The purple glove syndrome, a variant of

    this reaction, occurred in up to 5.9% of patients in one

    Mayo series.57

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    33/41

    .

    Despite this rapid administration, it is

    unclear whether

    fosphenytoin controls seizures faster

    than phenytoin.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    34/41

    .

    Phenobarbital.

    Phenobarbital is a barbiturate thatprevents seizure activity by increasing GABAA-mediated

    cellular inhibition

    third-line drug in algorithms designed to

    treat SE because of its serious adverse effect profile.14

    Phenobarbital profoundly depresses respiration andconsciousness

    level with a half-life of more than 48 hours. In

    addition, it causes severe hypotension secondary toperipheral

    vasodilation and decreased cardiac contractility.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    35/41

    RECENT ADDITION

    IV Valproic Acid and Other Medications.

    Valproicacid is a short-chain fatty acid with anticonvulsant properties.

    similar to phenytoin in that

    prolonged recovery of

    activated voltage-gated sodium channels. Other

    mechanismson

    neuronal calcium channels or through its effects on GABA

    metabolism.55 Valproate has been used previously

    Rectal form

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    36/41

    NO LONGER USED

    Lidocaine hydrochloride and

    paraldehyde have been

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    37/41

    nonpharmacological

    Including

    vagal nerve stimulation,

    plasmapheresis,

    electroconvulsive therapy,

    and surgical resection of cortical

    tissue,

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    38/41

    . refractory status epilepticus

    require treatment with anesthetic

    doses of benzodiazepines,

    short-acting barbiturates, or propofol.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    39/41

    .

    , isoflurane, a volatile

    Ketamine hydrochloride in controlling

    recalcitrant seizures

    neuroprotective because it

    simultaneously controls seizures

    and blocks glycine-activated NMDA

    receptors.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    40/41

    ,AIM

    20 minutes of treatment and did not

    return for at least 40

    minutes.

  • 7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt

    41/41

    THE FUTURE

    We need :-

    may involve both a GABA agonist to

    prevent seizures and an

    NMDA antagonist to prevent neuronal

    damage